Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

GEDCTerraVolt Holdings, Inc.

OTC · CIK 0001174891
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC6798 Real Estate Investment Trusts
FY end1231
XBRL facts338

Identity from submissions API

NameTerraVolt Holdings, Inc.
CIK0001174891
TickersGEDC
ExchangesOTC
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC6798 Real Estate Investment Trusts
EIN000000000
LEI—
Fiscal year end1231
State of incorporationNV NV
Phone713-929-3863
Website—
Investor website—
Owner org05 Real Estate & Construction
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • CalEthos, Inc. (2019-02-21T05:00:00.000Z → 2026-05-14T04:00:00.000Z)
  • RealSource Residential, Inc (2013-08-14T04:00:00.000Z → 2019-02-08T05:00:00.000Z)
  • UPSTREAM BIOSCIENCES INC. (2006-02-14T05:00:00.000Z → 2013-07-19T04:00:00.000Z)
  • FORCE ENERGY CORP. (2009-03-04T05:00:00.000Z → 2009-03-05T05:00:00.000Z)
  • INTEGRATED BRAND SOLUTIONS INC (2002-07-05T04:00:00.000Z → 2006-02-09T05:00:00.000Z)
Business address
THREE SUGAR CREEK CENTER
SUITE 100
SUGAR LAND
TX
77478
TX
Mailing address
THREE SUGAR CREEK CENTER
SUITE 100
SUGAR LAND
TX
77478
TX

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

337 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 10-Q 10-Q 0001493152-26-052029 000-50331 261555546 34 6652043 1 1
2026-10-30 8-K 8-K 1.01,7.01,9.01 0001493152-26-049362 000-50331 261504509 34 848343 1 1
2026-08-14 10-Q 10-Q 0001493152-26-038130 000-50331 261278303 34 4574422 1 1
2026-07-07 8-K 8-K 5.03,9.01 0001493152-26-032346 000-50331 261159696 34 2263059 1 1
2026-05-14 10-Q 10-Q 0001493152-26-022993 000-50331 26978078 34 4329763 1 1
2026-05-11 8-K 8-K 1.01,7.01,9.01 0001493152-26-022148 000-50331 26961002 34 280212 1 1
2026-05-04 DEF 14C DEF 14C 0001493152-26-021124 000-50331 26938368 34 215664
2026-04-29 8-K 8-K 1.01,3.02,9.01 0001493152-26-019595 000-50331 26916250 34 380643 1 1
2026-04-23 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001493152-26-018716 005-81555 26888705 34 38257
2026-04-23 4 4 0001493152-26-018711 16892
2026-04-16 4 4 0001493152-26-017080 9241
2026-04-16 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001493152-26-017078 005-81555 26867529 34 103382
2026-04-01 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001493152-26-014752 005-81555 26830311 34 7562825
2026-04-01 4/A 4/A 0001493152-26-014750 15215
2026-04-01 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001493152-26-014592 005-81555 26827146 34 4382344
2026-04-01 3/A 3/A 0001493152-26-014590 12182
2026-04-01 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001493152-26-014516 005-81555 26824745 34 11900
2026-03-31 10-K 10-K 0001493152-26-014045 000-50331 26820863 34 8043912 1 1
2026-02-04 144 xsl144X01/primary_doc.xml 0001520138-26-000050 000-50331 26599739 33 5646
2025-12-18 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001493152-25-028258 005-81555 251581215 34 32127
2025-12-18 4 4 0001493152-25-028255 9091
2025-12-12 4 4 0001493152-25-027606 5536
2025-11-14 10-Q 10-Q 0001493152-25-023306 000-50331 251484485 34 4564051 1 1
2025-08-14 10-Q 10-Q 0001641172-25-023834 000-50331 251216726 34 4549580 1 1
2025-08-13 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001641172-25-023537 005-81555 251212397 34 10548
2025-08-13 3 3 0001641172-25-023529 6114
2025-05-14 10-Q 10-Q 0001641172-25-010244 000-50331 25944967 34 3715441 1 1
2025-04-28 4 xslF345X05/ownership.xml 0001641172-25-006517 13413
2025-04-02 10-K form10-k.htm 0001641172-25-002190 000-50331 25801508 34 7104545 1 1
2025-04-01 NT 10-K formnt10-k.htm 0001641172-25-002069 000-50331 25799596 34 40389
2025-04-01 4 xslF345X05/ownership.xml 0001641172-25-002026 5548
2024-12-17 4 xslF345X05/ownership.xml 0001493152-24-050491 16950
2024-12-17 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001493152-24-050489 005-81555 241557247 34 129769
2024-11-19 10-Q form10-q.htm 0001493152-24-046748 000-50331 241474881 34 4217546 1 1
2024-11-14 NT 10-Q formnt10-q.htm 0001493152-24-045350 000-50331 241457284 34 42563
2024-10-22 4 xslF345X05/ownership.xml 0001493152-24-042073 9787
2024-09-05 D xslFormDX01/primary_doc.xml 06b 0001493152-24-035025 021-523203 241279135 33 13879
2024-08-14 10-Q form10-q.htm 0001493152-24-032034 000-50331 241206063 34 4151258 1 1
2024-08-01 8-K form8-k.htm 1.01,9.01 0001493152-24-029802 000-50331 241163579 34 244455 1 1
2024-06-26 D xslFormDX01/primary_doc.xml 06b 0001493152-24-025275 021-517022 241073805 33 13881
2024-05-15 10-Q form10-q.htm 0001493152-24-019662 000-50331 24948885 34 3644618 1 1
2024-04-09 10-K form10-k.htm 0001493152-24-014061 000-50331 24832524 34 6265832 1 1
2024-04-02 NT 10-K formnt10-k.htm 0001493152-24-012554 000-50331 24811464 34 39560
2024-03-14 SC 13D/A formsc13da.htm 0001493152-24-009936 005-81555 24749185 34 63617
2024-03-14 SC 13D formsc13d.htm 0001493152-24-009918 005-81555 24748851 34 55652
2024-03-12 8-K form8-k.htm 1.01,3.02,9.01 0001493152-24-009681 000-50331 24743072 34 253948 1 1
2024-02-14 4 xslF345X05/ownership.xml 0001493152-24-006786 9276
2024-01-03 4 xslF345X05/ownership.xml 0001493152-24-000268 15166
2024-01-03 4 xslF345X05/ownership.xml 0001493152-24-000267 11615
2024-01-03 3 xslF345X02/ownership.xml 0001493152-24-000270 4341
2024-01-03 4 xslF345X05/ownership.xml 0001493152-24-000269 7925
2024-01-03 3 xslF345X02/ownership.xml 0001493152-24-000266 6174
2023-12-07 8-K form8-k.htm 8.01,9.01 0001493152-23-043954 000-50331 231471136 34 11478208 1 1
2023-11-14 10-Q form10-q.htm 0001493152-23-040814 000-50331 231402025 34 3332864 1 1
2023-08-14 10-Q form10-q.htm 0001493152-23-028068 000-50331 231166548 34 3235257 1 1
2023-06-27 8-K form8-k.htm 5.02,9.01 0001493152-23-022635 000-50331 231047928 34 351046 1 1
2023-05-15 10-Q form10-q.htm 0001493152-23-017043 000-50331 23919669 34 2735457 1 1
2023-04-17 10-K form10-k.htm 0001493152-23-012482 000-50331 23823496 34 6506807 1 1
2023-03-28 NT 10-K formnt10-k.htm 0001493152-23-009309 000-50331 23770509 34 39733
2022-11-14 10-Q form10-q.htm 0001493152-22-031697 000-50331 221380967 34 3880889 1 1
2022-08-15 10-Q form10-q.htm 0001493152-22-022780 000-50331 221164922 34 3488801 1 1
2022-05-16 10-Q form10-q.htm 0001493152-22-013629 000-50331 22927419 34 2990392 1 1
2022-03-31 10-K form10-k.htm 0001493152-22-008391 000-50331 22791875 34 6329650 1 1
2021-12-06 3 xslF345X02/ownership.xml 0001493152-21-030554 5198
2021-11-15 10-Q form10-q.htm 0001493152-21-028450 000-50331 211408608 34 3210543 1 1
2021-11-10 3 xslF345X02/ownership.xml 0001493152-21-027863 3756
2021-11-10 4 xslF345X03/ownership.xml 0001493152-21-027815 6804
2021-11-09 3 xslF345X02/ownership.xml 0001213900-21-057544 6067
2021-10-21 DEF 14C formdef14c.htm 0001493152-21-025982 000-50331 211337154 34 207575
2021-10-08 8-K form8-k.htm 5.02 0001493152-21-025007 000-50331 211314285 34 213483 1 1
2021-10-05 PRE 14C formpre14c.htm 0001493152-21-024593 000-50331 211305689 34 207478
2021-09-23 D xslFormDX01/primary_doc.xml 06b 0001493152-21-023444 021-414375 211271850 33 6392
2021-09-21 8-K form8-k.htm 1.01,3.02,5.02,9.01 0001493152-21-023242 000-50331 211266082 34 1035639 1 1
2021-08-16 10-Q form10-q.htm 0001493152-21-020005 000-50331 211175929 34 2660910 1 1
2021-07-20 8-K form8-k.htm 8.01,9.01 0001493152-21-017274 000-50331 211099533 34 65390
2021-07-14 10-Q form10-q.htm 0001493152-21-016817 000-50331 211089826 34 1775678 1
2021-06-30 10-K form10-k.htm 0001493152-21-015690 000-50331 211061720 34 3198703 1
2021-06-29 10-Q form10-q.htm 0001493152-21-015533 000-50331 211057713 34 1990091 1
2021-06-29 10-Q form10-q.htm 0001493152-21-015531 000-50331 211057638 34 1939176 1
2021-06-29 10-Q form10-q.htm 0001493152-21-015529 000-50331 211057619 34 1766979 1
2020-04-15 8-K form8-k.htm 1.02 0001493152-20-006450 000-50331 20793417 34 31936
2020-03-30 10-K form10-k.htm 0001493152-20-005276 000-50331 20758301 34 2995190 1
2020-01-17 8-K form8-k.htm 1.01,7.01,9.01 0001493152-20-000736 000-50331 20533516 34 795480
2019-11-13 10-Q form10-q.htm 0001493152-19-016987 000-50331 191212445 34 1610124 1
2019-08-14 10-Q form10-q.htm 0001493152-19-012497 000-50331 191025979 34 1552252 1
2019-06-06 SC 13D/A formsc13da.htm 0001493152-19-008816 005-81555 19883165 34 68678
2019-05-15 10-Q form10-q.htm 0001493152-19-007237 000-50331 19825949 34 1292465 1
2019-04-26 4/A xslF345X03/ownership.xml 0001493152-19-006034 10649
2019-04-26 4 xslF345X03/ownership.xml 0001493152-19-006031 7693
2019-04-01 10-K form10-k.htm 0001493152-19-004523 000-50331 19720751 34 2232279 1
2019-02-21 D xslFormDX01/primary_doc.xml 06b 0001493152-19-002326 021-333228 19619980 33 7438
2019-02-08 8-K form8-k.htm 5.03,9.01 0001493152-19-001624 000-50331 19581113 34 910571
2018-11-14 10-Q form10-q.htm 0001493152-18-016178 000-50331 181184874 34 944956 1
2018-10-30 DEF 14C formdef14c.htm 0001493152-18-014987 000-50331 181146724 34 104816
2018-10-29 8-K form8-k.htm 3.03,4.01,9.01 0001493152-18-014909 000-50331 181143482 34 373906
2018-10-16 PRE 14C formpre14c.htm 0001493152-18-014554 000-50331 181124348 34 104786
2018-09-28 4 xslF345X03/ownership.xml 0001493152-18-013902 6170
2018-09-26 D xslFormDX01/primary_doc.xml 06b 0001493152-18-013766 021-322231 181088622 33 7044
2018-09-24 SC 13D formsc13d.htm 0001493152-18-013690 005-81555 181084250 34 53312
2018-09-24 SC 13D formsc13d.htm 0001493152-18-013685 005-81555 181084239 34 110574
2018-09-14 8-K form8-k.htm 1.01,3.02,5.01,5.02,5.03,9.01 0001493152-18-013297 000-50331 181071896 34 200593
2018-09-14 3 xslF345X02/ownership.xml 0001213900-18-012539 7150
2018-09-14 3 xslF345X02/ownership.xml 0001213900-18-012537 4598
2018-08-29 SC 14F1 formsc14f-1.htm 0001493152-18-012674 005-81555 181042773 34 119073
2018-08-29 8-K form8-k.htm 3.03,5.03,9.01 0001493152-18-012673 000-50331 181042771 34 295123
2018-08-15 10-Q form10-q.htm 0001493152-18-012029 000-50331 181020790 34 1533200 1
2018-08-15 NT 10-Q nt10q.htm 0001493152-18-011970 000-50331 181019729 34 24193
2018-05-14 10-Q form10-q.htm 0001493152-18-006738 000-50331 18829123 34 1552218 1
2018-03-28 10-K form10-k.htm 0001493152-18-004019 000-50331 18718474 34 2323182 1
2017-10-27 10-Q form10q.htm 0001493152-17-012111 000-50331 171157814 34 2075269 1
2017-08-14 10-Q form10-q.htm 0001493152-17-009041 000-50331 171026717 34 2001824 1
2017-05-15 10-Q form10-q.htm 0001493152-17-005248 000-50331 17841586 34 2053792 1
2017-03-21 10-K form10-k.htm 0001493152-17-002669 000-50331 17703271 34 2705833 1
2016-11-14 10-Q form10-q.htm 0001493152-16-014847 000-50331 161991712 34 2492969 1
2016-08-15 10-Q form10-q.htm 0001493152-16-012360 000-50331 161830716 34 2384959 1
2016-05-16 10-Q form10-q.htm 0001493152-16-009824 000-50331 161651357 34 2278273 1
2016-03-30 10-K form10-k.htm 0001493152-16-008458 000-50331 161540672 34 2889428 1
2016-01-19 8-K form8-k.htm 1.01,9.01 0001493152-16-006843 000-50331 161348945 34 68221
2015-11-16 10-Q form10-q.htm 0001493152-15-005554 000-50331 151234527 34 2483179 1
2015-10-02 8-K form8-k.htm 4.01,9.01 0001493152-15-004669 000-50331 151141025 34 33192
2015-08-21 10-Q/A AMENDMENT NO. 1 0001387131-15-002630 000-50331 151069492 34 2410620 1
2015-08-19 10-Q QUARTERLY REPORT 0001387131-15-002606 000-50331 151064847 34 479440
2015-08-14 NT 10-Q NOTIFICATION OF LATE FILING 0001387131-15-002512 000-50331 151054912 34 22027
2015-05-20 10-Q QUARTERLY REPORT 0001387131-15-001818 000-50331 15879624 34 4196726 1
2015-05-15 NT 10-Q NOTIFICATION OF LATE FILING 0001387131-15-001773 000-50331 15870683 34 22507
2015-03-31 10-K ANNUAL REPORT 0001387131-15-001116 000-50331 15737489 34 4585154 1
2014-11-14 10-Q QUARTERLY REPORT 0001387131-14-003758 000-50331 141219998 34 3549920 1
2014-08-14 10-Q QUARTERLY REPORT 0001387131-14-003000 000-50331 141044002 34 3098613 1
2014-05-13 10-Q QUARTERLY REPORT 0001387131-14-001870 000-50331 14838476 34 3990478 1
2014-03-31 10-K/A AMENDMENT TO ANNUAL REPORT 0001387131-14-001213 000-50331 14730724 34 4728948 1
2014-03-27 10-K ANNUAL REPORT 0001387131-14-001092 000-50331 14722543 34 4605064 1
2014-01-14 10-K ANNUAL REPORT 0001387131-14-000132 000-50331 14528132 34 3587153 1
2014-01-10 SC 13D/A realsource-13da1_010914.htm 0001387131-14-000094 005-81555 14520179 34 65106
2014-01-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001387131-14-000027 5443
2014-01-02 4 OWNERSHIP DOCUMENT 0001387131-14-000025 5371
2014-01-02 4 OWNERSHIP DOCUMENT 0001387131-14-000023 5390
2014-01-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001387131-14-000021 5498
2013-12-31 NT 10-K LATE FILING NOTIFICATION 0001387131-13-004813 000-50331 131305954 34 18057
2013-12-20 D xslFormDX01/primary_doc.xml 06b 0001465818-13-000012 021-208447 131290694 33 7322
2013-12-17 4 OWNERSHIP DOCUMENT 0001387131-13-004707 20110
2013-12-17 4 OWNERSHIP DOCUMENT 0001387131-13-004705 14182
2013-12-17 4 OWNERSHIP DOCUMENT 0001387131-13-004703 24165
2013-12-13 8-K CURRENT REPORT 1.01,3.02,9.01 0001387131-13-004625 000-50331 131276944 34 424959
2013-08-15 10-Q/A QUARTERLY REPORT AMENDMENT NO. 1 0001387131-13-003060 000-50331 131043242 34 3018099 1
2013-08-14 10-Q QUARTERLY REPORT 0001387131-13-003032 000-50331 131039059 34 1094454
2013-07-19 8-K CURRENT REPORT 1.01,5.03,9.01 0001387131-13-002568 000-50331 13977704 34 1906604
2013-06-11 SC 13D upstream-13d.htm 0001387131-13-002168 005-81555 13904865 34 291427
2013-06-10 3 OWNERSHIP DOCUMENT 0001387131-13-002164 4717
2013-06-10 3 OWNERSHIP DOCUMENT 0001387131-13-002162 3984
2013-06-10 3 OWNERSHIP DOCUMENT 0001387131-13-002160 4757
2013-06-10 3 OWNERSHIP DOCUMENT 0001387131-13-002158 4773
2013-06-10 3 OWNERSHIP DOCUMENT 0001387131-13-002156 4120
2013-06-10 3 OWNERSHIP DOCUMENT 0001387131-13-002154 4735
2013-06-07 SC 14F1 STATEMENT REGARDING CHANGE IN MAJORITY OF DIRECTORS 0001387131-13-002129 005-81555 13901218 34 125206
2013-06-05 8-K CURRENT REPORT 5.01,5.02,9.01 0001387131-13-002102 000-50331 13892817 34 75009
2013-05-15 10-Q g6821.txt 0001165527-13-000489 000-50331 13848214 34 1506979 1
2013-04-22 8-K/A AMENDMENT NO. 1 TO FORM 8-K 1.01,3.02,9.01 0001165527-13-000404 000-50331 13774574 34 34086
2013-04-11 8-K CURRENT REPORT DATED 3-28-13 1.01,3.02,9.01 0001165527-13-000353 000-50331 13755887 34 35180
2013-04-10 3 FORM 3 0001140361-13-016185 4166
2013-02-14 10-Q g6618.txt 0001165527-13-000160 000-50331 13609053 34 1500005 1
2012-12-31 10-K g6516.txt 0001165527-12-001356 000-50331 121293378 34 2536224 1
2012-12-14 8-K CURRENT REPORT DATED 12-4-12 5.03,9.01 0001165527-12-001301 000-50331 121263188 34 7410
2012-12-12 8-K CURRENT REPORT DATED 12-6-12 4.01,9.01 0001165527-12-001293 000-50331 121257374 34 8354
2012-10-11 DEF 14A DEFINITIVE N & PS 0001165527-12-001060 000-50331 121140205 34 71122
2012-10-01 8-K CURRENT REPORT DATED 8-16-12 3.02,5.01,8.01 0001165527-12-001032 000-50331 121119300 34 5096
2012-09-25 3 FORM 3 0001140361-12-041517 3932
2012-09-11 PRE 14A PRELIMINARY N&PS 0001165527-12-000960 000-50331 121084724 34 71049
2012-08-20 10-Q g6219.txt 0001165527-12-000891 000-50331 121044314 34 714636 1
2012-08-14 NT 10-Q FORM 12B-25 OF UPSTREAM BIOSCIENCES 0001165527-12-000864 000-50331 121033387 34 6638
2012-08-09 D xslFormDX01/primary_doc.xml 06 0001085037-12-000157 021-182447 121019155 33 6285
2012-05-30 10-Q/A g6033.txt 0001165527-12-000583 000-50331 12877267 34 703030 1
2012-05-30 10-K/A g6032.txt 0001165527-12-000582 000-50331 12877234 34 1715143 1
2012-05-30 10-K/A AMENDMENT NO. 1 TO FORM 10-K 0001165527-12-000581 000-50331 12877205 34 205573
2012-05-30 10-K/A AMENDMENT NO. 1 TO FORM 10-K 0001165527-12-000580 000-50331 12877190 34 208477
2012-05-18 10-Q g6000a.txt 0001165527-12-000503 000-50331 12853178 34 692696 1
2012-05-16 NT 10-Q g6000.txt 0001165527-12-000492 000-50331 12847370 34 6517
2012-02-17 8-K FORM 8-K 5.02 0001085037-12-000026 000-50331 12620666 34 20804
2012-02-14 10-Q g5730.txt 0001165527-12-000123 000-50331 12606853 34 701739 1
2012-01-13 10-K g5682a.txt 0001165527-12-000026 000-50331 12527074 34 1711754 1
2011-12-29 NT 10-K FORM 12B-25 OF UPSTREAM BIOSCIENCES 0001165527-11-001250 000-50331 111286465 34 6677
2011-12-13 10-Q g5607.txt 0001165527-11-001189 000-50331 111257104 34 728689 1
2011-11-15 10-Q QTRLY REPORT FOR THE QTR ENDED 3-31-11 0001165527-11-001094 000-50331 111205250 34 84331
2011-10-28 10-Q QTRLY REPORT FOR THE QTR ENDED 112-31-10 0001165527-11-000999 000-50331 111164851 34 84009
2011-09-30 10-K ANNUAL REPORT FOR THE YEAR ENDED 9-30-2010 0001165527-11-000913 000-50331 111117757 34 203518
2011-08-10 10-Q QTRLY REPORT FOR THE QTR ENDED 6-30-2010 0001165527-11-000684 000-50331 111022441 34 86490
2011-07-26 10-Q QTRLY REPORT FOR THE QTR ENDED 3-31-10 0001165527-11-000662 000-50331 11986816 34 86228
2011-06-30 10-Q QTRLY REPORT FOR THE QTR ENDED 12-31-09 0001165527-11-000607 000-50331 11942919 34 89188
2011-06-10 10-K ANNUAL REPORT FOR THE YEAR ENDED 9-30-09 0001165527-11-000534 000-50331 11905497 34 207454
2010-12-16 10-Q/A AMENDMENT NO. 1 TO FORM 10-Q 0001165527-10-001013 000-50331 101257721 34 114658
2010-12-16 10-Q/A AMENDMENT NO. 1 TO FORM 10-Q 0001165527-10-001012 000-50331 101257713 34 115865
2010-12-16 10-K/A AMENDMENT NO. 1 TO FORM 10-K 0001165527-10-001011 000-50331 101257711 34 269620
2010-12-10 10-Q/A AMENDMENT NO 1 TO FORM 10-Q 0001165527-10-000985 000-50331 101244385 34 108435
2010-12-10 10-Q/A AMENDMENT NO. 1 FORM 10-Q 0001165527-10-000984 000-50331 101244383 34 110347
2010-12-10 10-Q/A AMENDMENT TO FORM 10-Q 0001165527-10-000983 000-50331 101244382 34 103283
2010-12-09 10-K/A AMENDMENT NO. 1 TO FORM 10-K 0001165527-10-000963 000-50331 101241880 34 255428
2010-12-01 10-Q/A AMENDMENT NO 1 TO FORM 10-Q 0001165527-10-000922 000-50331 101224498 34 116803
2010-12-01 10-Q/A AMENDMENT NO. 1 TO FORM 10-Q 0001165527-10-000916 000-50331 101222761 34 124014
2010-11-29 10-Q/A AMENDMENT NO. 1 TO FORM 10-Q 0001165527-10-000903 000-50331 101218096 34 124243
2010-11-26 10-KT/A AMENDMENT NO. 1 TO FORM 10-K 0001165527-10-000897 000-50331 101216285 34 222025
2010-11-19 10-Q/A AMENDMENT NO. 1 TO FORM 10-Q 0001165527-10-000882 000-50331 101205728 34 132659
2010-11-15 8-K FORM 8-K 8.01,9.01 0001085037-10-000353 000-50331 101190625 34 33549
2010-11-12 10-Q/A AMENDMENT NO. 2 TO FORM 10-Q 0001165527-10-000845 000-50331 101186311 34 135113
2010-03-29 UPLOAD filename1.pdf 0000000000-10-016840 17184
2010-02-05 CORRESP filename1.htm 0001062993-10-000358 6196
2009-12-30 NT 10-K FORM NT 0001085037-09-000729 000-50331 091264753 34 43259
2009-12-23 3 FORM 3 0001140361-09-030158 4301
2009-12-15 8-K FORM 8-K 1.01,1.02,2.01,2.06,3.02,5.02,7.01,9.01 0001085037-09-000705 000-50331 091240226 34 204757
2009-12-14 4 PRIMARY DOCUMENT 0001085037-09-000707 8655
2009-12-14 4 PRIMARY DOCUMENT 0001085037-09-000706 8692
2009-11-19 CORRESP filename1.htm 0001085037-09-000644 10654
2009-11-03 CORRESP filename1.htm 0001085037-09-000594 22238
2009-10-28 CORRESP filename1.htm 0001085037-09-000564 10411
2009-09-04 UPLOAD filename1.pdf 0000000000-09-049373 24066
2009-09-01 10-Q QUARTERLY REPORT FOR THE PERIOD ENDED JUNE 30, 2009 0001062993-09-003147 000-50331 091047271 34 739218
2009-08-31 8-K form8k.htm 4.02 0001062993-09-003127 000-50331 091046932 34 10077
2009-08-14 NT 10-Q FORM NT 0001085037-09-000442 000-50331 091016691 34 35526
2009-08-11 8-K FORM 8-K 8.01,9.01 0001085037-09-000436 000-50331 091004659 34 26866
2009-05-15 10-Q QUARTERLY REPORT FOR THE PERIOD ENDED MARCH 31, 2009 0001062993-09-001732 000-50331 09831837 34 208871
2009-04-27 UPLOAD filename1.pdf 0000000000-09-022079 16050
2009-03-04 UPLOAD filename1.pdf 0000000000-09-011255 34872
2009-02-17 10-Q QUARTERLY REPORT FOR THE PERIOD ENDED DECEMBER 31, 2008 0001062993-09-000567 000-50331 09613290 34 195365
2009-02-02 CORRESP filename1.htm 0001085037-09-000072 15514
2009-02-02 10-K/A AMENDED ANNUAL REPORT FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 2008 0001062993-09-000344 000-50331 09560581 34 605976
2008-12-22 10-K ANNUAL REPORT FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 2008 0001062993-08-005413 000-50331 081262331 34 657378
2008-08-14 10QSB QUARTERLY REPORT FOR THE PERIOD ENDED JUNE 30, 2008 0001062993-08-003627 000-50331 081018509 34 184164
2008-05-15 10QSB QUARTERLY REPORT FOR THE PERIOD ENDED MARCH 31, 2008 0001062993-08-002262 000-50331 08836201 34 487123
2008-04-23 3 xslF345X02/f3geert_ex.xml 0001085037-08-000435 3418
2008-04-18 8-K FORM 8-K 7.01,9.01 0001085037-08-000419 000-50331 08763851 34 25728
2008-04-16 8-K FORM 8-K 5.02,8.01 0001085037-08-000408 000-50331 08759674 34 26501
2008-04-11 3 xslF345X02/f3bacha_ex.xml 0001085037-08-000382 3346
2008-03-27 8-K FORM 8-K 5.02,8.01 0001085037-08-000322 000-50331 08713123 34 24162
2008-02-14 10QSB QUARTERLY REPORT FOR THE PERIOD ENDED DECEMBER 31, 2007 0001062993-08-000637 000-50331 08619101 34 460498
2007-12-26 10KSB ANNUAL REPORT FOR THE PERIOD ENDED SEPTEMBER 30, 2007 0001062993-07-005146 000-50331 071327319 34 610090
2007-10-25 424B4 form424.htm 0001062993-07-004208 333-146432 071189011 33 652264
2007-10-18 EFFECT xslEFFECTX01/primary_doc.xml SB-2,,2007-10-18 12:00:00 9999999995-07-004117 333-146432 071179928 33 2233
2007-10-01 SB-2 formsb2.htm 0001062993-07-003809 333-146432 071146958 33 2194529
2007-08-27 8-K FORM 8-K 2.01,3.02,9.01 0001085037-07-001960 000-50331 071080034 34 31416
2007-08-23 8-K FORM 8-K 1.01,9.01 0001085037-07-001938 000-50331 071075662 34 456379
2007-08-14 10QSB QUARTERLY REPORT FOR THE PERIOD ENDED JUNE 30, 2007 0001062993-07-003118 000-50331 071053832 34 210630
2007-07-10 8-K FORM 8-K 7.01,9.01 0001085037-07-001602 000-50331 07972802 34 20589
2007-05-25 4 PRIMARY DOCUMENT 0001085037-07-001270 5825
2007-05-25 4 PRIMARY DOCUMENT 0001085037-07-001269 6507
2007-05-25 4 PRIMARY DOCUMENT 0001085037-07-001268 6510
2007-05-18 S-8 s8051807.htm 0001085037-07-001201 333-143097 07865476 33 238033
2007-05-15 10QSB form10qsb.htm 0001062993-07-001840 000-50331 07855118 34 1222812
2007-05-07 8-K f8k050307.htm 3.02,9.01 0001085037-07-001020 000-50331 07824585 34 15754
2007-04-30 4 PRIMARY DOCUMENT 0001085037-07-000946 4129
2007-04-30 3 PRIMARY DOCUMENT 0001085037-07-000945 3357
2007-04-30 8-K f8k043007.htm 5.02,8.01,9.01 0001085037-07-000942 000-50331 07799476 34 21878
2007-04-18 3 PRIMARY DOCUMENT 0001085037-07-000863 3320
2007-03-29 8-K f8k032707.htm 5.02 0001085037-07-000675 000-50331 07726413 34 9326
2007-03-19 8-K f8k022607.htm 1.01,3.02 0001085037-07-000616 000-50331 07703310 34 10294
2007-02-14 10QSB form10qsb.htm 0001062993-07-000519 000-50331 07622639 34 220382
2007-01-08 UPLOAD filename1.pdf 0000000000-07-000782 38713
2007-01-04 10KSB TRANSITION REPORT FOR THE PERIOD FROM JANUARY 1, 2006 TO SEPTEMBER 30, 2006 0001062993-07-000030 000-50331 07506680 34 456432
2007-01-03 NT 10-K nt093006ksb.htm 0001085037-07-000013 000-50331 07503166 34 28294
2006-11-30 8-K f8k112706.htm 5.03,9.01 0001085037-06-002384 000-50331 061248689 34 191839
2006-10-11 DEF 14C def14c.htm 0001085037-06-001987 000-50331 061140398 34 85334
2006-10-06 8-K FORM 8-K 7.01,9.01 0001085037-06-001970 000-50331 061134507 34 17835
2006-10-04 PRER14C prer14c.htm 0001085037-06-001945 000-50331 061129242 34 109716
2006-09-27 8-K FORM 8-K 7.01,9.01 0001085037-06-001887 000-50331 061110885 34 18267
2006-09-22 PRE 14C prelim14c.htm 0001085037-06-001866 000-50331 061104222 34 83550
2006-09-14 8-K f8k091306.htm 7.01,9.01 0001085037-06-001799 000-50331 061091192 34 17576
2006-09-13 8-K f8k091106.htm 8.01 0001085037-06-001787 000-50331 061087778 34 8759
2006-09-12 CORRESP filename1.htm 0001085037-06-001780 20945
2006-09-11 10QSB/A AMENDMENT NO. 1 TO QUARTERLY REPORT FOR THE PERIOD ENDED MARCH 31, 2006 0001062993-06-002787 000-50331 061084906 34 223700
2006-09-01 8-K f8k083106.htm 7.01,9.01 0001085037-06-001723 000-50331 061070895 34 17668
2006-08-31 CORRESP filename1.htm 0001085037-06-001717 10277
2006-08-31 CORRESP filename1.htm 0001085037-06-001715 20836
2006-08-21 10QSB QUARTERLY REPORT FOR THE PERIOD ENDED JUNE 30, 2006 0001062993-06-002535 000-50331 061046905 34 226521
2006-08-16 UPLOAD filename1.pdf 0000000000-06-039357 37183
2006-08-14 8-K f8k081006.htm 4.02 0001085037-06-001582 000-50331 061031629 34 10596
2006-08-14 NT 10-Q nt063006qsb.htm 0001085037-06-001552 000-50331 061026362 34 28298
2006-07-13 8-K f8k071306.htm 4.01,5.03,9.01 0001085037-06-001384 000-50331 06959814 34 22981
2006-06-14 8-K FORM 8-K 7.01,9.01 0001085037-06-001212 000-50331 06904631 34 21376
2006-05-24 8-K FORM 8-K 7.01,9.01 0001085037-06-001093 000-50331 06863587 34 12338
2006-05-15 10QSB FORM 10-QSB 0001085037-06-001015 000-50331 06839964 34 350250
2006-05-08 8-K FORM 8-K 7.01,9.01 0001085037-06-000936 000-50331 06815639 34 18957
2006-04-26 8-K FORM 8-K 7.01,9.01 0001085037-06-000811 000-50331 06780393 34 19888
2006-04-12 3 PRIMARY DOCUMENT 0001085037-06-000729 5871
2006-04-12 8-K FORM 8-K 5.02,9.01 0001085037-06-000722 000-50331 06756416 34 22864
2006-04-07 8-K FORM 8-K 7.01 0001085037-06-000708 000-50331 06748529 34 8885
2006-03-22 8-K FORM 8-K FOR THE PERIOD OF MARCH 21, 2006 7.01,9.01 0001085037-06-000583 000-50331 06703859 34 11843
2006-03-13 SC 13D SCHEDULE 13D - JOEL BELLENSON 0001085037-06-000494 005-81555 06681468 34 42773
2006-03-13 SC 13D SCHEDULE 13D - DEXSTER SMITH 0001085037-06-000492 005-81555 06681391 34 42664
2006-03-10 4 PRIMARY DOCUMENT 0001085037-06-000488 5276
2006-03-10 3 PRIMARY DOCUMENT 0001085037-06-000487 3972
2006-03-10 3/A PRIMARY DOCUMENT 0001085037-06-000486 4046
2006-03-10 3 PRIMARY DOCUMENT 0001085037-06-000485 3969
2006-03-10 8-K FORM 8-K CHANGE OF AUDITORS 4.01,9.01 0001085037-06-000474 000-50331 06679154 34 16414
2006-03-10 4 PRIMARY DOCUMENT 0001085037-06-000461 5503
2006-03-07 8-K FORM 8-K 1.01,2.01,2.03,3.02,5.01,5.02,5.06,9.01 0001085037-06-000437 000-50331 06670579 34 1777509
2006-03-03 8-K FORM 8-K 8.01,9.01 0001085037-06-000408 000-50331 06662382 34 14016
2006-02-27 8-K FORM 8-K 1.01,1.02,9.01 0001085037-06-000371 000-50331 06644511 34 358514
2006-02-14 SC 14F1 SCHEDULE 14F1 0001085037-06-000289 005-81555 06612782 34 104436
2006-02-09 8-K FORM 8-K 5.03,9.01 0001085037-06-000243 000-50331 06591837 34 168054
2006-02-06 8-K FORM 8-K 1.01 0001085037-06-000209 000-50331 06579413 34 367068
2006-01-26 10QSB FORM 10-QSB 0001085037-06-000166 000-50331 06554062 34 192039
2005-12-29 8-K FORM 8-K 5.03,9.01 0001085037-05-001900 000-50331 051291036 34 16020
2005-11-01 10QSB FORM 10-QSB 0001085037-05-001540 000-50331 051169568 34 186824
2005-09-27 8-K FORM 8-K 1.02,9.01 0001085037-05-001394 000-50331 051104661 34 26643
2005-08-02 10QSB FORM 10-QSB 0001085037-05-001115 000-50331 05991882 34 160669
2005-07-21 8-K FORM 8-K 1.01,9.01 0001085037-05-001061 000-50331 05966436 34 20700
2005-06-29 10KSB/A FORM 10-KSB/A 0001085037-05-000927 000-50331 05922136 34 320087
2005-06-28 10KSB FORM 10-KSB 0001085037-05-000923 000-50331 05919919 34 320011
2005-05-26 8-K f8k052605.htm 5.02 0001085037-05-000765 000-50331 05860145 34 8476
2005-03-10 8-K f8k030805.htm 5.03,9.01 0001085037-05-000300 000-50331 05670321 34 21926
2005-02-14 10QSB f10qsb123104.htm 0001085037-05-000184 000-50331 05601227 34 71446
2004-11-15 10QSB f10qsb093004.htm 0001085037-04-001246 000-50331 041141268 34 70607
2004-08-23 10QSB f10qsb063004.htm 0001085037-04-000907 000-50331 04989768 67905
2004-08-20 8-K f8k082004.htm 4,7 0001085037-04-000906 000-50331 04989764 8017
2004-08-16 NT 10-Q june30nt.htm 0001085037-04-000886 000-50331 04979824 7487
2004-07-06 10KSB/A f10ksb033104.htm 0001085037-04-000694 000-50331 04901154 142484
2004-07-02 10KSB f10ksb033104.htm 0001085037-04-000688 000-50331 04900700 117892
2004-06-30 NT 10-K f12b25mar31.htm 0001085037-04-000675 000-50331 04889761 9709
2004-05-05 4 PRIMARY DOCUMENT 0001085037-04-000436 4638
2004-05-05 4 PRIMARY DOCUMENT 0001085037-04-000435 4695
2004-05-04 3 PRIMARY DOCUMENT 0001085037-04-000430 3108
2004-05-04 8-K/A f8ka.htm 6,9 0001085037-04-000429 000-50331 04777183 5191
2004-05-04 8-K f8k.htm 6,9 0001085037-04-000427 000-50331 04777081 5171
2004-02-20 10QSB dec3110qsb.htm 0001085037-04-000164 000-50331 04619247 62767
2004-02-18 NT 10-Q f12b25dec31.htm 0001085037-04-000152 000-50331 04612414 7672
2003-11-19 10QSB f10qsb093003.htm 0001085037-03-000822 000-50331 031012552 73193
2003-11-17 NT 10-Q f12b25.htm 0001085037-03-000804 000-50331 031006280 7644
2003-08-21 10QSB form10qsb-0630.htm 0001156214-03-000036 000-50331 03858931 30067
2003-08-15 NT 10-Q integrated1225-081503.htm 0001218360-03-000091 000-50331 03850885 8124
2003-07-02 3 PRIMARY DOCUMENT 0001218360-03-000082 3433
2003-07-02 3 PRIMARY DOCUMENT 0001218360-03-000081 3443
2003-07-01 8-A12G ibs8a-010703.htm 0001218360-03-000080 000-50331 03768969 222614
2003-07-01 10KSB ibs10k-310303.htm 0001218360-03-000078 333-92034 03768300 97304
2003-07-01 NT 10-K integrated1225-070103.htm 0001218360-03-000076 333-92034 03767562 7982
2003-03-20 10QSB ibs10qsb-123102.htm 0001218360-03-000018 333-92034 03610577 36014
2003-01-28 SB-2/A sb2a-128.htm 0001156214-03-000009 333-92034 03527262 160373
2002-12-16 SB-2/A sb2a-1216.htm 0001156214-02-000076 333-92034 02858994 158008
2002-11-07 SB-2/A ibs-sb2a1107.htm 0001156214-02-000055 333-92034 02812632 148354
2002-08-28 SB-2/A ibs-sb2a.htm 0001156214-02-000041 333-92034 02750810 140348
2002-07-05 SB-2 ibs-sb2.htm 0001156214-02-000026 333-92034 02697310 182491

Latest XBRL company facts

One latest value per concept from companyfacts (338 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 25.73M 2026-11-13 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
dei EntityListingParValuePerShare Entity Listing, Par Value Per Share USD/shares 0.001 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
dei EntityPublicFloat Entity Public Float USD 8.36M 2025-06-30 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 1.46M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 218,000 2023-12-31 2023 FY 10-K 2024-04-09 0001493152-24-014061
us-gaap AccountsPayableTradeCurrent Accounts Payable, Trade, Current USD 270,000 2021-09-30 2021 Q3 10-Q 2021-11-15 0001493152-21-028450
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 900 2013-06-30 2013 Q3 10-Q/A 2013-08-15 0001387131-13-003060
us-gaap AccretionExpense Accretion Expense USD 6.38M 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-17 0001493152-23-012482
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 72,000 2024-03-31 2024 Q1 10-Q 2024-05-15 0001493152-24-019662
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 330,000 2023-12-31 2023 FY 10-K 2024-04-09 0001493152-24-014061
us-gaap AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD -11,838 2014-03-31 2014 Q1 10-Q 2014-05-13 0001387131-14-001870
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 9,000 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap AdditionalCollateralAggregateFairValue Additional Collateral, Aggregate Fair Value USD 37.50M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001493152-26-038130
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 38.42M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap AdjustmentForAmortization Amortization USD 278,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001493152-24-032034
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD 239,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-06-30 0001493152-21-015690
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 260,000 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 77,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 577,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-06-30 0001493152-21-015690
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 52,000 2021-01-01 2021-03-31 2022 Q1 10-Q 2022-05-16 0001493152-22-013629
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 2.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium USD 58,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-31 0001493152-22-008391
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 236,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap AllocatedShareBasedCompensationExpenseNetOfTax Share-based Payment Arrangement, Expense, after Tax USD 1.66M 2004-06-15 2011-09-30 2011 FY 10-K/A 2012-05-30 0001165527-12-000582
us-gaap AmortizationOfAcquisitionCosts Amortization of Acquisition Costs USD 133,600 2004-06-14 2011-12-31 2012 Q1 10-Q/A 2012-05-30 0001165527-12-000583
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 644,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 40,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 487,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0001493152-23-017043
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 30.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 154,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-09 0001493152-24-014061
us-gaap Assets Assets USD 13.55M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap AssetsCurrent Assets, Current USD 4.20M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap BusinessAcquisitionPercentageOfVotingInterestsAcquired Business Acquisition, Percentage of Voting Interests Acquired pure 0.9 2013-05-24 2018 Q2 10-Q 2018-08-15 0001493152-18-012029
us-gaap BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement Business Acquisition, Preacquisition Contingency, Amount of Settlement USD 90,000 2022-06-09 2022 FY 10-K 2023-04-17 0001493152-23-012482
us-gaap BusinessCombinationConsiderationTransferred1 Business Combination, Consideration Transferred USD 80,000 2018-05-15 2018-05-16 2020 Q1 10-Q 2021-06-29 0001493152-21-015529
us-gaap Cash Cash USD 194,162 2015-06-30 2015 Q2 10-Q 2015-08-21 0001387131-15-002630
us-gaap CashAcquiredInExcessOfPaymentsToAcquireBusiness Cash Acquired in Excess of Payments to Acquire Business USD 180,000 2018-05-15 2018-05-16 2020 Q1 10-Q 2021-06-29 0001493152-21-015529
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 4.03M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 180,000 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-15 0001493152-19-007237
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 10.03M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 10.03M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 9.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap CashUninsuredAmount Cash, Uninsured Amount USD 9.78M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.5 2026-04-23 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight Class of Warrant or Right, Number of Securities Called by Each Warrant or Right shares 6.00M 2026-04-23 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 100,000 2021-09-15 2022 FY 10-K 2023-04-17 0001493152-23-012482
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 1.68M 2023-09-30 2023 Q3 10-Q 2023-11-14 0001493152-23-040814
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 100.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 25.73M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 25.73M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap CommonStockShareSubscribedButUnissuedSubscriptionsReceivable Common Stock, Share Subscribed but Unissued, Subscriptions Receivable USD 0 2014-12-31 2014 FY 10-K 2015-03-31 0001387131-15-001116
us-gaap CommonStockValue Common Stock, Value, Issued USD 26,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap CommunicationsAndInformationTechnology Communications and Information Technology USD 258,349 2004-06-15 2014-03-31 2014 Q1 10-Q 2014-05-13 0001387131-14-001870
us-gaap CompensationExpenseExcludingCostOfGoodAndServiceSold Compensation Expense, Excluding Cost of Good and Service Sold USD 577,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-06-30 0001493152-21-015690
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -6.51M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -5.74M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001493152-25-023306
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 15.75M 2018-12-18 2018-12-20 2020 FY 10-K 2021-06-30 0001493152-21-015690
us-gaap ConvertibleDebt Convertible Debt USD 115,000 2023-12-31 2023 FY 10-K 2024-04-09 0001493152-24-014061
us-gaap ConvertibleDebtCurrent Convertible Debt, Current USD 1.62M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap ConvertibleDebtNoncurrent Convertible Debt, Noncurrent USD 1.31M 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 341,000 2023-12-31 2024 FY 10-K 2025-04-02 0001641172-25-002190
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 242,000 2019-12-31 2019 FY 10-K 2020-03-30 0001493152-20-005276
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 753,000 2021-03-31 2021 Q1 10-Q 2021-07-14 0001493152-21-016817
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 5.26M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001493152-23-040814
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 4.21M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001493152-23-040814
us-gaap DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1 Debt Conversion, Converted Instrument, Warrants or Options Issued shares 2.31M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-15 0001493152-18-012029
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD 4.61M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001493152-23-040814
us-gaap DebtInstrumentConvertibleBeneficialConversionFeature Debt Instrument, Convertible, Beneficial Conversion Feature USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-17 0001493152-23-012482
us-gaap DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent Debt Instrument, Convertible, Carrying Amount of Equity Component USD 100,000 2020-03-31 2020 Q1 10-Q 2021-06-29 0001493152-21-015529
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 2 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap DebtInstrumentConvertibleConversionPriceDecrease Debt Instrument, Convertible, Conversion Price, Decrease USD/shares 1.25 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001493152-21-028450
us-gaap DebtInstrumentDecreaseForgiveness Debt Instrument, Decrease, Forgiveness USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-31 0001387131-15-001116
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 1.00M 2024-12-15 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap DebtInstrumentIncreaseAccruedInterest Debt Instrument, Increase, Accrued Interest USD 80,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage pure 0.1 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.1 2021-09-30 2021 Q3 10-Q 2021-11-15 0001493152-21-028450
us-gaap DebtInstrumentPeriodicPaymentInterest Debt Instrument, Periodic Payment, Interest USD 1.99M 2016-02-01 2016-02-29 2017 FY 10-K 2018-03-28 0001493152-18-004019
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 102,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense Deferred Compensation Arrangement with Individual, Allocated Share-based Compensation Expense USD 46,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 45,000 2018-12-31 2018 FY 10-K 2019-04-01 0001493152-19-004523
us-gaap DeferredIncomeTaxesAndTaxCredits Deferred Income Taxes and Tax Credits USD -57,415 2004-06-14 2012-06-30 2012 Q3 10-Q 2012-08-20 0001165527-12-000891
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -57,415 2004-06-15 2014-03-31 2014 Q1 10-Q 2014-05-13 0001387131-14-001870
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 1,000 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 4.55M 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2015-12-31 2015 FY 10-K 2016-03-30 0001493152-16-008458
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 1.71M 2022-12-31 2022 FY 10-K 2023-04-17 0001493152-23-012482
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 4.10M 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 3.07M 2022-12-31 2022 FY 10-K 2023-04-17 0001493152-23-012482
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 802,000 2022-12-31 2022 FY 10-K 2023-04-17 0001493152-23-012482
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 453,000 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Impairment Losses USD 38,000 2022-12-31 2022 FY 10-K 2023-04-17 0001493152-23-012482
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 4.55M 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap DeferredTaxLiabilitiesNoncurrent Deferred Tax Liabilities, Net, Noncurrent USD 0 2011-09-30 2011 FY 10-K/A 2012-05-30 0001165527-12-000582
us-gaap DepletionOfOilAndGasProperties Depletion of Oil and Gas Properties USD 479,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap DepositLiabilitiesAccruedInterest Deposit Liabilities, Accrued Interest USD 500,000 2016-02-29 2017 FY 10-K 2018-03-28 0001493152-18-004019
us-gaap Deposits Deposits USD 1.54M 2014-03-31 2014 Q1 10-Q 2014-05-13 0001387131-14-001870
us-gaap DepositsAssets Deposits Assets USD 1.56M 2014-06-30 2014 Q2 10-Q 2014-08-14 0001387131-14-003000
us-gaap DepositsAssetsCurrent Deposits Assets, Current USD 1.56M 2015-12-31 2016 FY 10-K 2017-03-21 0001493152-17-002669
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 1.56M 2015-09-30 2015 Q3 10-Q 2015-11-16 0001493152-15-005554
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 133,600 2004-06-15 2014-03-31 2014 Q1 10-Q 2014-05-13 0001387131-14-001870
us-gaap DevelopmentCosts Development Costs, Period Cost USD 4.58M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001493152-25-023306
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 7.37M 2014-06-30 2014 Q2 10-Q 2014-08-14 0001387131-14-003000
us-gaap DistributionFees Distribution Fees (Deprecated 2018-01-31) USD 19,799 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-20 0001387131-15-001818
us-gaap DividendsSharebasedCompensationStock Dividend, Share-based Payment Arrangement, Shares USD 1.66M 2004-06-15 2014-03-31 2014 Q1 10-Q 2014-05-13 0001387131-14-001870
us-gaap DueFromOfficersOrStockholdersCurrent Due from Officers or Stockholders, Current USD 12,000 2018-12-31 2019 FY 10-K 2020-03-30 0001493152-20-005276
us-gaap DueFromRelatedPartiesCurrent Due from Related Parties, Current USD 364,784 2015-12-31 2016 FY 10-K 2017-03-21 0001493152-17-002669
us-gaap DueFromRelatedPartiesNoncurrent Due from Related Parties, Noncurrent USD 102,698 2015-09-30 2015 Q3 10-Q 2015-11-16 0001493152-15-005554
us-gaap DueToAffiliateCurrent Due to Affiliate, Current USD 0 2013-06-30 2013 FY 10-K 2014-01-14 0001387131-14-000132
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 0 2014-12-31 2014 FY 10-K 2015-03-31 0001387131-15-001116
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.15 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.35 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-31 0001493152-22-008391
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.15 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.306 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.05 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.078 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD -2,590 2004-06-15 2014-03-31 2014 Q1 10-Q 2014-05-13 0001387131-14-001870
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD -1,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 2.26M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount Share-based Payment Arrangement, Amount Capitalized USD 947,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 0.5 2020-12-31 2020 FY 10-K 2021-06-30 0001493152-21-015690
us-gaap EquityMethodInvestmentRealizedGainLossOnDisposal Equity Method Investment, Realized Gain (Loss) on Disposal USD -369,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-02 0001641172-25-002190
us-gaap EquityMethodInvestments Equity Method Investments USD 198,271 2015-12-31 2016 FY 10-K 2017-03-21 0001493152-17-002669
us-gaap EscrowDeposit Escrow Deposit USD 84,000 2023-03-30 2023 Q3 10-Q 2023-11-14 0001493152-23-040814
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 2.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2013-01-01 2013-12-31 2014 Q2 10-Q 2014-08-14 0001387131-14-003000
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 0.614 2013-01-01 2013-12-31 2014 Q2 10-Q 2014-08-14 0001387131-14-003000
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.015 2013-01-01 2013-12-31 2014 Q2 10-Q 2014-08-14 0001387131-14-003000
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 148,000 2022-12-31 2022 FY 10-K 2023-04-17 0001493152-23-012482
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD 15,544 2004-06-15 2014-03-31 2014 Q1 10-Q 2014-05-13 0001387131-14-001870
us-gaap GainLossOnDispositionOfProperty Gain (Loss) on Disposition of Property (Deprecated 2013-01-31) USD 78,570 2004-06-15 2014-03-31 2014 Q1 10-Q 2014-05-13 0001387131-14-001870
us-gaap GainLossOnSaleOfProperty Gain (Loss) on Disposition of Oil and Gas and Timber Property USD 78,570 2004-06-15 2014-03-31 2014 Q1 10-Q 2014-05-13 0001387131-14-001870
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 78,570 2004-06-14 2012-06-30 2012 Q3 10-Q 2012-08-20 0001165527-12-000891
us-gaap GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee USD -126,515 2004-06-14 2011-12-31 2012 Q1 10-Q/A 2012-05-30 0001165527-12-000583
us-gaap GainOrLossOnSaleOfStockInSubsidiary Gain (Loss) on Disposition of Stock in Subsidiary USD 8,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -6.47M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap GainsLossesOnSalesOfInvestmentRealEstate Gains (Losses) on Sales of Investment Real Estate USD 3,666 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-28 0001493152-18-004019
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 32,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 154,000 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-15 0001493152-22-022780
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 154,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-17 0001493152-23-012482
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 154,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001493152-22-031697
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 59,010 2004-06-15 2014-03-31 2014 Q1 10-Q 2014-05-13 0001387131-14-001870
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -3.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -7.19M 2004-06-14 2012-06-30 2012 Q3 10-Q 2012-08-20 0001165527-12-000891
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-14 0001493152-16-014847
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-21 0001387131-15-002630
us-gaap IncomeTaxExpenseBenefitContinuingOperations Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) USD -1,763 2011-10-01 2012-09-30 2012 FY 10-K 2012-12-31 0001165527-12-001356
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 617 2011-10-01 2012-09-30 2012 FY 10-K 2012-12-31 0001165527-12-001356
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 10.00M 2020-01-01 2020-12-31 2020 FY 10-K 2021-06-30 0001493152-21-015690
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 761,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -900 2004-06-15 2013-06-30 2013 Q3 10-Q/A 2013-08-15 0001387131-13-003060
us-gaap IncreaseDecreaseInAccruedInterestReceivableNet Increase (Decrease) in Accrued Interest Receivable, Net USD -364,784 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-28 0001493152-18-004019
us-gaap IncreaseDecreaseInDeposits Increase (Decrease) in Deposits USD -25,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-31 0001387131-15-001116
us-gaap IncreaseDecreaseInDueFromRelatedParties Increase (Decrease) in Due from Related Parties USD 0 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-14 0001387131-14-003000
us-gaap IncreaseDecreaseInDueFromRelatedPartiesCurrent Increase (Decrease) in Due from Related Parties, Current USD -705 2004-06-15 2013-06-30 2013 Q3 10-Q/A 2013-08-15 0001387131-13-003060
us-gaap IncreaseDecreaseInDueToRelatedPartiesCurrent Increase (Decrease) in Due to Related Parties, Current USD 271,984 2004-06-15 2014-03-31 2014 Q1 10-Q 2014-05-13 0001387131-14-001870
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD 0 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-20 0001387131-15-001818
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 155,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 3,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001493152-25-023306
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 0 2004-06-15 2011-09-30 2011 FY 10-K/A 2012-05-30 0001165527-12-000582
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 721,006 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-09 0001493152-24-014061
us-gaap IncrementalCommonSharesAttributableToConversionOfDebtSecurities Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities shares 4.13M 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-17 0001493152-23-012482
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 10.00M 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-09 0001493152-24-014061
us-gaap IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss Indefinite-lived Intangible Assets, Foreign Currency Translation Gain (Loss) USD 6,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-04-17 0001493152-23-012482
us-gaap IntangibleAssetsCurrent Intangible Assets, Current USD 69,000 2022-09-30 2022 Q3 10-Q 2022-11-14 0001493152-22-031697
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 74,000 2022-03-31 2022 Q1 10-Q 2022-05-16 0001493152-22-013629
us-gaap InterestAndDebtExpense Interest and Debt Expense USD 652,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001493152-23-040814
us-gaap InterestExpense Interest Expense USD 310,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-14 0001641172-25-010244
us-gaap InterestExpenseDebt Interest Expense, Debt USD 114,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0001493152-23-017043
us-gaap InterestExpenseOther Interest Expense, Other USD 176,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-13 0001493152-19-016987
us-gaap InterestIncomeOther Interest Income, Other USD -1 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-15 0001493152-18-012029
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 42,225 2016-01-01 2016-06-30 2017 Q2 10-Q 2017-08-14 0001493152-17-009041
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 100,000 2025-01-01 2025-03-31 2026 Q1 10-Q 2026-05-14 0001493152-26-022993
us-gaap InterestPayableCurrent Interest Payable, Current USD 122,000 2023-12-31 2023 FY 10-K 2024-04-09 0001493152-24-014061
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 122,000 2023-12-31 2023 FY 10-K 2024-04-09 0001493152-24-014061
us-gaap InterestReceivable Interest Receivable USD 241,135 2015-03-31 2015 Q1 10-Q 2015-05-20 0001387131-15-001818
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 102,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap Investments Investments USD 475,000 2015-12-31 2016 FY 10-K 2017-03-21 0001493152-17-002669
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 1.49M 2004-06-15 2014-03-31 2014 Q1 10-Q 2014-05-13 0001387131-14-001870
us-gaap LaborAndRelatedExpense Labor and Related Expense USD 758,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap Liabilities Liabilities USD 17.37M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 13.55M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap LiabilitiesCurrent Liabilities, Current USD 3.08M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 2.31M 2015-12-31 2016 FY 10-K 2017-03-21 0001493152-17-002669
us-gaap LiabilitiesOtherThanLongtermDebtNoncurrent Liabilities, Other than Long-term Debt, Noncurrent USD 2.31M 2014-06-30 2014 Q2 10-Q 2014-08-14 0001387131-14-003000
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 6.00M 2026-08-31 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap LongTermDebtFairValue Long-term Debt, Fair Value USD 1.00M 2024-02-29 2024 FY 10-K 2025-04-02 0001641172-25-002190
us-gaap LossContingencyDamagesSoughtValue Loss Contingency, Damages Sought, Value USD 450,000 2022-01-02 2022-01-03 2022 FY 10-K 2023-04-17 0001493152-23-012482
us-gaap MarketableSecurities Marketable Securities USD 475,000 2016-12-31 2017 FY 10-K 2018-03-28 0001493152-18-004019
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 15.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -3.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -1.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -3.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -756,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-06-30 0001493152-21-015690
us-gaap NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1 Noncash or Part Noncash Acquisition, Other Assets Acquired USD 38,000 2022-01-01 2022-03-31 2023 Q1 10-Q 2023-05-15 0001493152-23-017043
us-gaap NoncashProjectAbandonmentCosts Noncash Project Abandonment Costs USD 4.58M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -1.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap NotesPayable Notes Payable USD 7,000 2023-12-31 2023 FY 10-K 2024-04-09 0001493152-24-014061
us-gaap NotesPayableCurrent Notes Payable, Current USD 11,000 2025-03-31 2025 Q1 10-Q 2025-05-14 0001641172-25-010244
us-gaap NotesPayableToBankCurrent Notes Payable to Bank, Current USD 51,000 2021-03-31 2021 Q1 10-Q 2021-07-14 0001493152-21-016817
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap OfficersCompensation Salary and Wage, Officer, Excluding Cost of Good and Service Sold USD 1.53M 2004-06-15 2014-03-31 2014 Q1 10-Q 2014-05-13 0001387131-14-001870
us-gaap OperatingExpenses Operating Expenses USD 2.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -2.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 7.42M 2024-12-31 2024 FY 10-K 2025-04-02 0001641172-25-002190
us-gaap OtherAdditionalCapital Other Additional Capital USD 58,000 2021-03-31 2021 Q1 10-Q 2021-07-14 0001493152-21-016817
us-gaap OtherAssets Other Assets USD 1.43M 2023-09-30 2023 Q3 10-Q 2023-11-14 0001493152-23-040814
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 3.35M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -9,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -1,000 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-15 0001493152-22-022780
us-gaap OtherCostAndExpenseOperating Other Cost and Expense, Operating USD 106,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 4,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001493152-25-023306
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 50,086 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-21 0001387131-15-002630
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 0 2011-09-30 2011 FY 10-K/A 2012-05-30 0001165527-12-000582
us-gaap OtherShortTermInvestments Other Short-term Investments USD 120,834 2015-03-31 2015 Q1 10-Q 2015-05-20 0001387131-15-001818
us-gaap OtherTaxExpenseBenefit Other Tax Expense (Benefit) USD -617 2011-10-01 2012-09-30 2012 FY 10-K 2012-12-31 0001165527-12-001356
us-gaap PaymentsForDeposits Payments for Deposits USD -1.54M 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-28 0001493152-18-004019
us-gaap PaymentsForFees Payments for Other Fees USD 479,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap PaymentsForProceedsFromInvestments Payments for (Proceeds from) Investments USD -475,000 2014-01-01 2014-12-31 2015 FY 10-K 2016-03-30 0001493152-16-008458
us-gaap PaymentsForProceedsFromLoansAndLeases Payments for (Proceeds from) Loans and Leases USD 37.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap PaymentsForRent Payments for Rent USD 4,000 2022-01-02 2022-01-03 2022 FY 10-K 2023-04-17 0001493152-23-012482
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 10,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 20,000 2025-04-01 2025-04-30 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD -51,507 2004-06-14 2013-03-31 2013 Q2 10-Q 2013-05-15 0001165527-13-000489
us-gaap PaymentsToAcquireEquityMethodInvestments Payments to Acquire Equity Method Investments USD 390,117 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-14 0001387131-14-003000
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 37,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0001493152-22-013629
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD -475,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-31 0001387131-15-001116
us-gaap PaymentsToAcquireMachineryAndEquipment Payments to Acquire Machinery and Equipment USD -22,764 2004-06-14 2012-06-30 2012 Q3 10-Q 2012-08-20 0001165527-12-000891
us-gaap PaymentsToAcquireOilAndGasProperty Payments to Acquire Oil and Gas Property USD 3.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap PaymentsToAcquireOtherProductiveAssets Payments to Acquire Other Productive Assets USD 84,000 2023-01-01 2023-03-31 2024 Q1 10-Q 2024-05-15 0001493152-24-019662
us-gaap PaymentsToAcquireProductiveAssets Payments to Acquire Productive Assets USD -22,764 2004-06-15 2014-03-31 2014 Q1 10-Q 2014-05-13 0001387131-14-001870
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 525,000 2023-06-22 2023-06-23 2023 Q3 10-Q 2023-11-14 0001493152-23-040814
us-gaap PaymentsToFundLongtermLoansToRelatedParties Payments to Fund Long-term Loans to Related Parties USD -12,000 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-14 0001493152-19-012497
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 100.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 16,000 2018-09-30 2018 Q3 10-Q 2018-11-14 0001493152-18-016178
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 163,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 1,000 2022-09-30 2022 Q3 10-Q 2022-11-14 0001493152-22-031697
us-gaap PrepaidInsurance Prepaid Insurance USD 23,000 2025-09-30 2025 Q3 10-Q 2025-11-14 0001493152-25-023306
us-gaap ProceedsFromCollectionOfLongtermLoansToRelatedParties Proceeds from Collection of Long-term Loans to Related Parties USD 12,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-13 0001493152-19-016987
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 215,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates Proceeds from Divestiture of Interest in Subsidiaries and Affiliates USD 1 2004-06-15 2014-03-31 2014 Q1 10-Q 2014-05-13 0001387131-14-001870
us-gaap ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital Proceeds from Equity Method Investment, Distribution, Return of Capital USD 3,666 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-28 0001493152-18-004019
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 13.48M 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-09 0001493152-24-014061
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 69,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-06-30 0001493152-21-015690
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 225,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 147,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-06-30 0001493152-21-015690
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 15.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap ProceedsFromPaymentsForLongTermLoansForRelatedParties Proceeds from Collection of (Payments to Fund) Long-term Loans to Related Parties USD 12,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-06-30 0001493152-21-015690
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 15.00M 2026-04-23 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap ProceedsFromRepaymentsOfRelatedPartyDebt Proceeds from (Repayments of) Related Party Debt USD 321,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001493152-25-023306
us-gaap ProceedsFromSaleOfEquityMethodInvestments Proceeds from Sale of Equity Method Investments USD 1 2004-06-14 2012-06-30 2012 Q3 10-Q 2012-08-20 0001165527-12-000891
us-gaap ProceedsFromSaleOfOtherReceivables Proceeds from Sale of Other Receivables USD -10,259 2004-06-15 2014-03-31 2014 Q1 10-Q 2014-05-13 0001387131-14-001870
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 2,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-04-17 0001493152-23-012482
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 2,000 2021-01-01 2021-06-30 2022 Q2 10-Q 2022-08-15 0001493152-22-022780
us-gaap ProfessionalFees Professional Fees USD 443,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -22,677 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-21 0001387131-15-002630
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 0 2011-09-30 2011 FY 10-K/A 2012-05-30 0001165527-12-000582
us-gaap RelatedPartyTransactionDueFromToRelatedPartyCurrent Related Party Transaction, Due from (to) Related Party, Current USD 705 2013-06-30 2013 Q3 10-Q/A 2013-08-15 0001387131-13-003060
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 50,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-09 0001493152-24-014061
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 1.42M 2004-06-15 2014-03-31 2014 Q1 10-Q 2014-05-13 0001387131-14-001870
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 6.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -42.27M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap Revenues Revenues USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-19 0001493152-24-046748
us-gaap RoyaltyExpense Royalty Expense USD 114,384 2004-06-15 2014-03-31 2014 Q1 10-Q 2014-05-13 0001387131-14-001870
us-gaap SettlementLiabilitiesCurrent Settlement Liabilities, Current USD 9,000 2018-09-30 2019 FY 10-K 2020-03-30 0001493152-20-005276
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 714,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage pure 1 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-31 0001493152-22-008391
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 Share-based Payment Arrangement, Expensed and Capitalized, Amount USD 2.26M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding USD 423,000 2019-12-31 2019 FY 10-K 2020-03-30 0001493152-20-005276
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments USD 0 2021-01-01 2021-12-31 2022 FY 10-K 2023-04-17 0001493152-23-012482
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0.041 2024-02-01 2024-02-29 2024 FY 10-K 2025-04-02 0001641172-25-002190
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 2.146 2025-04-01 2025-04-30 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 1.59 2024-02-01 2024-02-29 2024 FY 10-K 2025-04-02 0001641172-25-002190
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.039 2025-04-01 2025-04-30 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations shares 100,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-02 0001641172-25-002190
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures shares 600,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted shares 6.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number shares 17.50M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 695,000 2023-12-31 2023 FY 10-K 2024-04-09 0001493152-24-014061
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 253,000 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-15 0001493152-22-022780
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 1.84M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value USD/shares 578,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-06-30 0001493152-21-015690
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 2.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0.23 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 2.68M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value USD/shares 2.08 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 0.52 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 0 2025-09-30 2025 Q3 10-Q 2025-11-14 0001493152-25-023306
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 9.22M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 0.62 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 20,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 6.54M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 0.58 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 561,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-04-17 0001493152-23-012482
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 350,000 2025-05-01 2025-05-31 2026 Q1 10-Q 2026-05-14 0001493152-26-022993
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0.001 2021-01-01 2021-12-31 2022 FY 10-K 2023-04-17 0001493152-23-012482
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 12.5 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-31 0001493152-22-008391
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 2.33 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0.52 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap SharePrice Share Price USD/shares 0.49 2025-04-30 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 1.93 2022-09-30 2022 Q3 10-Q 2022-11-14 0001493152-22-031697
us-gaap ShortTermInvestments Short-term Investments USD 475,000 2015-03-31 2015 Q1 10-Q 2015-05-20 0001387131-15-001818
us-gaap StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants USD 100,000 2021-09-14 2021-09-15 2021 Q3 10-Q 2021-11-15 0001493152-21-028450
us-gaap StockGrantedDuringPeriodValueSharebasedCompensation Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture USD -11.17M 2022-07-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001493152-22-031697
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -3.82M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap StockholdersEquityNoteSubscriptionsReceivable Stockholders' Equity Note, Subscriptions Receivable USD 1,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap StockIssued1 Stock Issued USD 1.00M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap StockIssuedDuringPeriodSharesAcquisitions Stock Issued During Period, Shares, Acquisitions shares 11.01M 2018-05-15 2018-05-16 2020 Q1 10-Q 2021-06-29 0001493152-21-015529
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 10,000 2021-11-04 2021-11-05 2023 Q2 10-Q 2023-08-14 0001493152-23-028068
us-gaap StockIssuedDuringPeriodSharesOther Stock Issued During Period, Shares, Other shares 3.74M 2016-02-01 2016-02-29 2017 FY 10-K 2018-03-28 0001493152-18-004019
us-gaap StockIssuedDuringPeriodSharesReverseStockSplits Stock Issued During Period, Shares, Reverse Stock Splits shares 440,256 2018-05-15 2018-05-16 2020 Q1 10-Q 2021-06-29 0001493152-21-015529
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 1.44M 2021-01-01 2021-12-31 2022 FY 10-K 2023-04-17 0001493152-23-012482
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD -119,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-31 0001493152-22-008391
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments USD 35,000 2013-01-01 2013-12-31 2014 Q2 10-Q 2014-08-14 0001387131-14-003000
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 575,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-04-17 0001493152-23-012482
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 6.93M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 875,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 3.21M 2022-04-01 2022-06-30 2023 Q3 10-Q 2023-11-14 0001493152-23-040814
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 197,000 2023-07-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001493152-23-040814
us-gaap StockIssuedDuringPeriodValueShareBasedCompensationForfeited Shares Issued, Value, Share-based Payment Arrangement, Forfeited USD 11.17M 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-09 0001493152-24-014061
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 2,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-04-17 0001493152-23-012482
us-gaap StockOptionPlanExpense Stock or Unit Option Plan Expense USD 98,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-09 0001493152-24-014061
us-gaap TaxAdjustmentsSettlementsAndUnusualProvisions Tax Adjustments, Settlements, and Unusual Provisions USD 800 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-02 0001641172-25-002190
us-gaap ValuationAllowanceAmount Valuation Allowance, Amount (Deprecated 2013-01-31) USD -156,619 2013-12-31 2013 FY 10-K/A 2014-03-31 0001387131-14-001213
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 1.99M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap ValuationAllowancesAndReservesPeriodIncreaseDecrease SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease) USD 8,329 2012-10-01 2013-09-30 2013 FY 10-K 2014-01-14 0001387131-14-000132
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 755,000 2024-12-15 2025 FY 10-K 2026-03-31 0001493152-26-014045
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 14.85M 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-09 0001493152-24-014061
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 25.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 19.48M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-31 0001493152-22-008391
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 2.49M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001493152-22-031697
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 25.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001493152-26-052029

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →